Nortech (NSYS) Q2 2026 earnings review
Strong Demand Masked by Surging Operating Expenses
Nortech delivered solid 9.3% year-over-year revenue growth and expanded gross margins to 17.0%. However, the turnaround narrative hits a significant snag further down the income statement. A sudden 24% spike in operating expenses—driven largely by General & Administrative costs—erased the gross profit gains. Consequently, operating income declined 16% year-over-year, and EBITDA fell 12.6%. While management touts the benefits of past restructuring, the lack of operating leverage and a reversal in inventory management are concerning.
🐂 Bull Case
Total backlog surged 20% YoY to $93.8 million, and the 90-day backlog grew to $33.4 million. This provides high visibility and indicates strong customer demand, particularly in the Aerospace & Defense sectors.
Gross profit margins expanded to 17.0% from 15.8% a year ago, proving that facility consolidations and manufacturing efficiencies at the plant level are bearing fruit.
🐻 Bear Case
Despite higher sales and better gross margins, operating income fell 16%. General & Administrative expenses jumped 25.5% YoY, completely neutralizing the benefits of top-line growth.
Management previously promised to reduce inventory to boost cash flow. Instead, inventory has climbed by nearly $4 million over the last six months, driving year-to-date operating cash flow into negative territory (-$2.4 million).
⚖️ Verdict: ⚪
Neutral. Top-line demand is undeniably Accelerating, and the nearshoring thesis is playing out. However, the unexpected deterioration in expense control and working capital management prevents a bullish rating until management proves they can drop revenue to the bottom line.
Key Themes
Backlog Accelerating on A&D Strength
Nortech is successfully converting customer engagement into booked orders. The total backlog accelerated to $93.8 million, a 20% increase YoY and up sequentially from $90.8 million in 26Q1. The 90-day backlog also grew significantly to $33.4 million (up 25.5% YoY). This provides a highly defensive revenue pipeline heading into the second half of 2026.
Reversing Course on Operating Leverage
Management's narrative heavily relies on 'restructuring actions and disciplined execution.' However, Q2 data explicitly contradicts this at the operating level. General & Administrative expenses exploded to $3.25 million (up 25.5% YoY), and Selling expenses rose to $1.48 million (up 23% YoY). This OPEX bloat dragged operating margins down to 1.9% from 2.4% last year, signaling a severe lack of scale efficiency.
Inventory Build Contradicts Prior Cash Flow Guidance
In mid-2025, management explicitly stated plans to reduce inventory investments to strengthen the balance sheet and improve cash flow. The data shows a Reversing trend: inventory has steadily climbed from $18.6 million in 25Q2 to $20.7 million at year-end, and now sits at $24.5 million in 26Q2. This working capital drag resulted in negative $2.45 million in year-to-date operating cash flow.
Macro Tailwinds: Nearshoring & Tariffs
The company continues to lean into geopolitical uncertainty as a primary sales tool. Management highlighted customer interest in regional manufacturing strategies, leveraging their North American footprint (Minnesota and Monterrey, Mexico under the USMCA). This structure acts as a buffer against supply chain disruptions and mitigates direct exposure to standard U.S. import tariffs, positioning them well to win displaced contracts.
Other KPIs
Accelerating. Up from 15.8% in 25Q2 and 15.5% in 26Q1. This confirms that the messy plant consolidations and transfers (specifically the Blue Earth closure) are finally yielding the promised factory-level efficiencies and better pricing mix.
Decelerating. Dropped 12.6% year-over-year from $1.07 million. Adjusted EBITDA perfectly mirrors unadjusted EBITDA for the quarter, revealing that the profitability decline is purely operational (OPEX bloat) rather than driven by one-time restructuring charges.
Key Questions
G&A Expense Spike
General and Administrative expenses surged 25.5% year-over-year in Q2. What specific investments or structural changes drove this massive increase, and should investors view this $3.25 million run-rate as the new normal?
Inventory Management Reversal
Last year, management emphasized reducing inventory to generate free cash flow. Since year-end, inventory has grown by nearly $4 million. Is this a deliberate strategy to secure long-lead components for the growing backlog, or a symptom of delayed customer shipments?
Operating Leverage Timeline
Given the impressive gross margin expansion to 17%, at what quarterly revenue threshold do you expect OPEX to stabilize so the company can finally demonstrate meaningful operating leverage to the bottom line?